ESR1 and breast carcinoma: This association, which did not vary by estrogen receptor (ER) status, was one of the most significant associations found for breast cancer risk in Breast cancer 1 (BRCA1) mutation carriers so far, and the association was predominantly found in carriers with ER-negative (ER-(-)) breast cancer [2, 3].